Modular Medical financials
$1.95−2.74%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q1 '27 Jun 30 | Q4 '26 Mar 31 | Q3 '26 Dec 31 | Q2 '26 Sep 30 | Q1 '26 Jun 30 | Q4 '25 Mar 31 | Q3 '25 Dec 31 | Q2 '25 Sep 30 | Q1 '25 Jun 30 | Q4 '24 Mar 31 | Q3 '24 Dec 31 | Q2 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$6.5M | -$5.7M | -$7.2M | -$7.8M | -$6.8M | -$5.0M | -$4.9M | -$5.0M | -$4.2M | -$4.3M | -$5.3M | -$4.2M |
| Net income | -$6.5M | -$6.4M | -$7.4M | -$7.8M | -$6.7M | -$4.9M | -$4.8M | -$5.0M | -$4.1M | -$4.3M | -$5.3M | -$4.2M |
| Net margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-1.19 | — | $-3.30 | $-4.20 | $-3.70 | $-3.52 | $-3.90 | $-4.20 | $-3.60 | $-4.68 | $-6.90 | $-5.70 |
| EBITDA | -$6.0M | -$5.2M | -$6.8M | -$7.4M | -$6.4M | -$4.7M | -$4.6M | -$4.7M | -$4.0M | -$4.2M | -$5.1M | -$4.1M |
| Operating cash flow | -$6.0M | -$5.8M | -$7.2M | -$5.4M | -$5.4M | -$4.3M | -$4.1M | -$3.8M | -$3.5M | -$3.5M | -$4.0M | -$3.3M |
| Free cash flow | -$6.7M | -$6.8M | -$8.4M | -$6.2M | -$6.3M | -$5.3M | -$4.6M | -$3.9M | -$4.4M | -$4.0M | -$4.5M | -$3.6M |
| Diluted shares | 5.5M | — | 2.2M | 1.9M | 1.8M | 1.4M | 1.3M | 1.1M | 1.1M | 0.9M | 0.8M | 0.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.9M | $6.9M | $2.9M | $5.3M | $7.5M | $13.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $12.3M | $14.8M | $10.3M | $13.0M | $14.2M | $18.7M |
| Total liabilities | $1.5M | $1.9M | $4.4M | $4.2M | $2.3M | $1.7M |
| Shareholders' equity | $10.8M | $13.0M | $5.9M | $8.8M | $11.8M | $17.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology